OptimizeRx Corp (OPRX) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
OptimizeRx Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • OptimizeRx Corp Operating Income (Loss) for the quarter ending March 31, 2024 was -$5.03 M, a 28.8% increase year-over-year.
  • OptimizeRx Corp Operating Income (Loss) for the twelve months ending March 31, 2024 was -$24.4 M, a 56.3% decline year-over-year.
  • OptimizeRx Corp annual Operating Income (Loss) for 2023 was -$26.4 M, a 115% decline from 2022.
  • OptimizeRx Corp annual Operating Income (Loss) for 2022 was -$12.3 M, a 3504% decline from 2021.
  • OptimizeRx Corp annual Operating Income (Loss) for 2021 was $361 K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$24.4 M -$5.03 M +$2.03 M +28.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$26.4 M -$10.9 M -$10 M -1161% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$16.4 M -$3.55 M +$203 K +5.41% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$16.6 M -$4.88 M -$973 K -24.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$15.6 M -$7.06 M -$3.3 M -87.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$12.3 M -$864 K -$1.49 M -239% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$10.8 M -$3.76 M -$3.79 M -9937% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.01 M -$3.91 M -$4.25 M -1249% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$2.76 M -$3.76 M -$3.12 M -489% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $361 K $621 K -$735 K -54.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.1 M $38.2 K +$215 K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $882 K $340 K +$1.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$514 K -$638 K +$1.62 M +71.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$2.14 M $1.36 M +$3.67 M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 -$5.81 M -$177 K +$1.81 M +91.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$7.62 M -$1.06 M -$1.54 M -320% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$6.08 M -$2.26 M -$2.39 M -1809% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.69 M -$2.32 M -$2.19 M -1748% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$1.5 M -$1.99 M -$2.21 M -990% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $710 K $480 K +$206 K +75.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $503 K $132 K +$323 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $180 K -$125 K +$114 K +47.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $66.3 K $223 K +$853 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$787 K $274 K +$644 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.43 M -$191 K +$699 K +78.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.13 M -$239 K +$129 K +35% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$2.26 M -$630 K -$380 K -153% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$1.88 M -$371 K +$232 K +38.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$2.11 M -$890 K -$529 K -146% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$1.58 M -$368 K +$48 K +11.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$1.63 M -$249 K -$337 K -385% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$1.29 M -$603 K -$445 K -282% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$848 K -$362 K -$250 K -225% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$597 K -$416 K -$647 K -280% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $49.1 K $87.6 K +$382 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$333 K -$158 K +$42.3 K +21.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$376 K -$111 K +$651 K +85.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.03 M $231 K +$810 K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$1.84 M -$295 K -$153 K -108% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.68 M -$200 K -$554 K -156% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$1.13 M -$762 K -$862 K -864% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$268 K -$580 K -$608 K -2145% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
Q3 2013 $341 K -$142 K -$35.5 K -33.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $376 K $354 K +$430 K Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-12
Q1 2013 -$54.2 K $99.8 K +$401 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-14
Q4 2012 -$455 K $28.4 K +$412 K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$867 K -$106 K +$303 K +74.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$1.17 M -$76.2 K +$344 K +81.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.51 M -$301 K -$60.5 K -25.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.45 M -$384 K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$409 K +$96 K +19% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$420 K +$455 K +52% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$240 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$505 K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-23
Q2 2010 -$875 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.